Received: 26 June 2020
Accepted: 5 July 2020
First Online: 17 July 2020
Ethics approval and consent to participate
: The study was approved by the Ethics Committee of the Jena University Hospital, reg. nr. 2020-1815-Daten.
: Not applicable.
: Outside of the study, AS has received consulting fees from AbbVie, Amgen, Celltrion, Janssen, MSD, Mundipharma, and Takeda; lecture fees and support for travel accommodation from AbbVie, Amgen, FalkFoundation, Janssen, MSD, and Takeda; and research funding from Abbvie and Celltrion.